1
0
0
(1 - 17 von 20
)
LinkedIn: Thomas Machnig - 主管, 全球医疗事务特色产品- CSL Behring | 领英
上领英,在全球领先职业社交平台查看Thomas Machnig的职业档案。Thomas的职业档案列出了7 个职位。查看Thomas的完整档案,结识职场人脉和查看相似公司的 ...
Wileyhttps://ascpt.onlinelibrary.wiley.com › ...Exposure‐Response Model of Subcutaneous C1‐Inhibitor ...
ascpt.onlinelibrary.wiley.com
von Y Zhang · · Zitiert von: 17 — Thomas Machnig,. Thomas Machnig. Department of Global Clinical Development/Medical Affairs, CSL Behring GmbH, Marburg, Germany. Search for more ...
Comparative Economics of On-Demand Treatment Options ...Journal of Allergy and Clinical Immunology
www.jacionline.org
von Z Panahloo · · Zitiert von: 5 — Zoya Panahloo. Zoya Panahloo. Affiliations. CSL Behring UK Ltd, Haywards Heath, United Kingdom · Thomas Machnig. Thomas Machnig. Affiliations. CSL Behring GmbH, ... von Z Panahloo · · Zitiert von: 5 — Zoya Panahloo. Zoya Panahloo. Affiliations. CSL Behring UK Ltd, Haywards Heath, United Kingdom · Thomas Machnig. Thomas Machnig. Affiliations. CSL Behring GmbH, ...
Clinical features of genetically characterized types of ...Orphanet Journal of Rare Diseases
ojrd.biomedcentral.com
von K Bork · · Zitiert von: 97 — Konrad Bork reports speaker fees from CSL Behring and Shire/Takeda, outside the submitted work; Thomas Machnig is a former employee of CSL ... von K Bork · · Zitiert von: 97 — Konrad Bork reports speaker fees from CSL Behring and Shire/Takeda, outside the submitted work; Thomas Machnig is a former employee of CSL ...
Efficacy of Different Medical Therapies for the Treatment of Acute...
www.sciencedirect.com
Thomas Machnig is an employee of CSL Behring. No institutional review board approval was required for this study. View full text. Copyright © The Authors ...
Indirect comparison of intravenous vs. subcutaneous C1 ...Allergy, Asthma & Clinical Immunology
aacijournal.biomedcentral.com
von JA Bernstein · · Zitiert von: 15 — John-Philip Lawo & Thomas Machnig. CSL Behring, King of Prussia, PA, USA. Girishanthy Krishnarajah. AMF Consulting, Inc., Los Angeles, CA, ...
Indirect comparison of intravenous vs. subcutaneous C1-inhibitor...
link.springer.com
John-Philip Lawo; & Thomas Machnig. CSL Behring, King of Prussia, PA, USA. Girishanthy Krishnarajah. AMF Consulting, Inc., Los Angeles, ...
Long-term health-related quality of life in patients treated with...
link.springer.com
· Marc A. Riedl. CSL Behring GmbHMarburg, Germany. John-Philip Lawo, Subhransu Prusty & Thomas Machnig.
Different Treatment Response Based on Dosing Regimen?Journal of Allergy and Clinical Immunology
www.jacionline.org
von K Bork · — Thomas Machnig. Thomas Machnig. Affiliations. CSL Behring GmbH, Marburg, Germany. Search for articles by this author. Timothy J. Craig. Timothy J. Craig. von K Bork · — Thomas Machnig. Thomas Machnig. Affiliations. CSL Behring GmbH, Marburg, Germany. Search for articles by this author. Timothy J. Craig. Timothy J. Craig.
Journal of Allergy and Clinical Immunology
www.jacionline.org
von K Bork · · Zitiert von: 1 — Thomas Machnig. Thomas Machnig. Affiliations. CSL Behring GmbH, Marburg, Germany. Search for articles by this author. Timothy J. Craig, DO FAAAAI. Timothy J ...
Long-term Health-related Quality of Life in Patients Treated ...Journal of Allergy and Clinical Immunology
www.jacionline.org
von WR Lumry · · Zitiert von: 1 — Thomas Machnig, MD, PhD. Thomas Machnig. Affiliations. CSL Behring GmbH, Marburg, Germany. Search for articles by this author. Show all authors. DOI:https://doi ... von WR Lumry · · Zitiert von: 1 — Thomas Machnig, MD, PhD. Thomas Machnig. Affiliations. CSL Behring GmbH, Marburg, Germany. Search for articles by this author. Show all authors. DOI:https://doi ...
Long-term health-related quality of life in patients treated ...Europe PMC
europepmc.org
von WR Lumry · · Zitiert von: 17 — ... Thomas Machnig. CSL Behring GmbHMarburg, Germany. Search articles by 'Thomas Machnig' · Machnig T,. Hilary Longhurst. von WR Lumry · · Zitiert von: 17 — ... Thomas Machnig. CSL Behring GmbHMarburg, Germany. Search articles by 'Thomas Machnig' · Machnig T,. Hilary Longhurst.
Amazon Web Services
s3-us-west-1.amazonaws.com
— We, Thomas Machnig, M.D. and Hanno Waldhauser, declare: 1. We are both permanent and full-time employees of CSL Behring. a. I, Thomas ...
Figshare
springernature.figshare.com
— ... Thomas Machnig, Timothy Craig. Additional file 2. COMPACT Study Committees, Investigators, and other Collaborators. Funding. CSL Behring ...
Thomas Machnig's research works | CSL Behring, HE and other...
www.researchgate.net
160+ million publication pages. 2.3+ billion citations. Join for free. Thomas Machnig's 58 research works with 923 citations and 5,880 reads, including: Healthcare utilization of patients with ...
Slides from collection CSL Behring ResearchF1000Research
f1000research.com
Thomas Machnig. PUBLISHED 12 Jan https://doi.org/. Fluid resuscitation in the ICU/sepsis - the use of albumin. Thomas Machnig. PUBLISHED 14 Apr
Slides from collection CSL Behring Research - F1000Research
f1000research.com
Read the latest peer reviewed CSL Behring Research articles and more on F1000Research
Alle Infos zum Namen "Thomas MacHnig"
sortiert nach Relevanz / Datum